DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Prifinium bromide
Prifinium bromide
Isopropamide Iodide
WITHOUTUS010307409B2 (12 ) United States Patent ( 10 ) Patent No
(12) United States Patent (10) Patent No.: US 9,283,192 B2 Mullen Et Al
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Effect of Antispasmodic Agents for the Treatment of Irritable Bowel Syndrome
Bulking Agents, Antispasmodics and Antidepressants for the Treatment of Irritable Bowel Syndrome (Review)
2021 Equine Prohibited Substances List
Meta-Analysis: the Treatment of Irritable Bowel Syndrome
Council of Europe Committee of Ministers (Partial
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
Method for Transplantation of Fertilized Ova Methode Zur Transplantation Von Befruchteten Eiern Methode De Transplantation D'un Ovule Feconde
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds S
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Irritable Bowel Syndrome: Full Guideline Draft (August 2007) DRAFT for CONSULTATION
Appendix D: Characteristics of Included Studies
Smart Pharmacology Lesson 7
Top View
Oil in the Treatment of Irritable Bowel Effect of Fibre, Antispasmodics, And
IBS-Monograph-2018.Pdf
Literature Search Strategy for Treatment of Stable
Irritable Bowel Syndrome: Pathophysiological and Pharmacological Aspects and Use of Otilonium Bromide Or Pinaverium Bromide
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2009/0098207 A1 Malakhov Et Al
Pharmaceutical Composition with Systemic Anticholineesterasic, Agonistic-Cholinergic and Antimuscarinic Activity
Non-Interventional Study Protocol
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Cholinotpopic Drugs
Pharmaceutical Appendix to the Tariff Schedule 2
QVA149 / Indacaterol / Glycopyrronium Bromide
Harmonized Tariff Schedule of the United States (2006) (Rev
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Irritable Bowel Syndrome American College of Gastroenterology Task Force on IBS American College of Gastroenterology Task Force on Irritable Bowel Syndrome
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Propantheline Bromide(BAN, Rinn)